These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular aberrations in human systemic lupus erythematosus. Tsokos GC; Kammer GM Mol Med Today; 2000 Nov; 6(11):418-24. PubMed ID: 11074367 [TBL] [Abstract][Full Text] [Related]
5. Immune cells and cytokines in systemic lupus erythematosus: an update. Kyttaris VC; Juang YT; Tsokos GC Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827 [TBL] [Abstract][Full Text] [Related]
6. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients. Fujii Y; Fujii K; Tanaka Y Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of systemic lupus erythematosus. Francis L; Perl A Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215 [TBL] [Abstract][Full Text] [Related]
8. B cell receptor signaling in human systemic lupus erythematosus. Pugh-Bernard AE; Cambier JC Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281 [TBL] [Abstract][Full Text] [Related]
9. T lymphocytes in systemic lupus erythematosus: an update. Kyttaris VC; Tsokos GC Curr Opin Rheumatol; 2004 Sep; 16(5):548-52. PubMed ID: 15314492 [TBL] [Abstract][Full Text] [Related]
10. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. Wong HK; Kammer GM; Dennis G; Tsokos GC J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075 [TBL] [Abstract][Full Text] [Related]
12. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. Blossom S; Chu EB; Weigle WO; Gilbert KM J Immunol; 1997 Nov; 159(9):4580-6. PubMed ID: 9379059 [TBL] [Abstract][Full Text] [Related]
13. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892 [TBL] [Abstract][Full Text] [Related]
14. The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets. Shao WH; Cohen PL Expert Rev Clin Immunol; 2014 May; 10(5):573-82. PubMed ID: 24678775 [TBL] [Abstract][Full Text] [Related]
15. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. Liossis SN; Kovacs B; Dennis G; Kammer GM; Tsokos GC J Clin Invest; 1996 Dec; 98(11):2549-57. PubMed ID: 8958217 [TBL] [Abstract][Full Text] [Related]
16. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689 [TBL] [Abstract][Full Text] [Related]
20. Altered signaling triggered by ligation of the TCR/CD3 receptor in T lymphocytes from patients with systemic lupus erythematosus: the road from anergy to autoimmunity. Blasini AM; RodrÃguez MA Int Rev Immunol; 2004; 23(3-4):265-72. PubMed ID: 15204088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]